Literature DB >> 28117220

Pancreatic cysts: Diagnostic accuracy and risk of inappropriate resections.

N de Pretis1, S Mukewar1, A Aryal-Khanal1, Y Bi1, N Takahashi2, S Chari3.   

Abstract

BACKGROUND: Pancreatic cystic neoplasms (PCN) frequently undergo surgery, given malignant potential. Pancreatic cyst surgery is associated with significant rates of morbidity and mortality. It is crucial to accurately characterize these lesions pre-operatively to avoid unnecessary surgery in patients with benign pancreatic cysts. AIM: We aimed to assess the correlation between pre-operative (pre-op) diagnosis based on imaging and clinical presentation, and post-operative (post-op) diagnosis based on histopathology in patients undergone pancreatic cyst surgery.
METHODS: From January 2000 to January 2012, we randomly selected 2000 patients with ICD-9 code 211.6 and 577.2. Amongst these we identified 281 patients undergone pancreas surgery. Patients with no pre-op imaging or non-cyst indication for surgery were excluded (n = 107). Imaging details, demographics, pre-operative physician diagnosis and histopathologic details of pancreatic cysts were recorded in 174 patients.
RESULTS: There was a discrepancy between the pre- and post-operative pancreatic cyst diagnosis in 54 (31%) patients. There was no difference in the proportion of various imaging studies (CT, EUS or MRI) between patients with a correct and patients with an incorrect pre-op diagnosis. The pre-op diagnosis was confirmed at pathology in 87.5% of the presumed SCNs, in 80% of the presumed pseudocysts, in 73.3% of the presumed BD-IPMNs, in 66.7% of the presumed MD/mixed-IPMNs and in 53.6% of the presumed MCNs. The accuracy of the pre-operative diagnosis of presumed MCN was significantly lower compared to the non-MCN cysts (53.6% vs. 75%; p = 0.037). Fourteen percent of resections were performed for asymptomatic benign cysts, preoperatively suspected to be potentially pre-malignant cysts.
CONCLUSION: In nearly 1 out of 3 patients undergone pancreas cyst surgery, there is a discrepancy between pre- and post-op diagnosis. Pre-op diagnosis of presumed MCN is more likely to be incorrect, compared to the other cysts.
Copyright © 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cystic neoplasms; Diagnostic accuracy; Pancreas

Mesh:

Year:  2017        PMID: 28117220     DOI: 10.1016/j.pan.2017.01.002

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  9 in total

Review 1.  Molecular Diagnostics and Testing for Pancreatic Cysts.

Authors:  Jaime de la Fuente; Shounak Majumder
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-27

Review 2.  Pancreatic Cysts: Diagnostic Role of EUS-Guided Microforceps Biopsy and Confocal Laser Endomicroscopy.

Authors:  Darina Kohoutova; Sameer Zar; Rudolf Repak; Panagiotis Vlavianos; Jan Bures
Journal:  Gastroenterol Res Pract       Date:  2019-09-12       Impact factor: 2.260

3.  Surveillance for pancreatic cancer in high-risk individuals.

Authors:  I C A W Konings; M I Canto; J A Almario; F Harinck; P Saxena; A L Lucas; F Kastrinos; D C Whitcomb; R E Brand; J Lachter; G Malleo; S Paiella; S Syngal; J R Saltzman; E M Stoffel; J E van Hooft; R H Hruban; J W Poley; P Fockens; M G Goggins; M J Bruno
Journal:  BJS Open       Date:  2019-07-02

4.  It's not all about the size-characteristics and risk factors for malignancy of mucinous cystic neoplasms of the pancreas.

Authors:  Philipp Höhn; Muhammed Abdussamed Soydemir; Andreas Minh Luu; Monika Janot-Matuschek; Andrea Tannapfel; Waldemar Uhl; Orlin Belyaev
Journal:  Ann Transl Med       Date:  2020-12

5.  Cost-effectiveness analysis of including contrast-enhanced ultrasound in management of pancreatic cystic neoplasms.

Authors:  Niccolo' Faccioli; Elena Santi; Giovanni Foti; Mirko D'Onofrio
Journal:  Radiol Med       Date:  2022-03-01       Impact factor: 6.313

Review 6.  Pancreatic Incidentaloma.

Authors:  Miłosz Caban; Ewa Małecka-Wojciesko
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

7.  Multiregion whole-exome sequencing of intraductal papillary mucinous neoplasms reveals frequent somatic KLF4 mutations predominantly in low-grade regions.

Authors:  Kohei Fujikura; Waki Hosoda; Matthäus Felsenstein; Qianqian Song; Johannes G Reiter; Lily Zheng; Violeta Beleva Guthrie; Natalia Rincon; Marco Dal Molin; Jonathan Dudley; Joshua D Cohen; Pei Wang; Catherine G Fischer; Alicia M Braxton; Michaël Noë; Martine Jongepier; Carlos Fernández-Del Castillo; Mari Mino-Kenudson; C Max Schmidt; Michele T Yip-Schneider; Rita T Lawlor; Roberto Salvia; Nicholas J Roberts; Elizabeth D Thompson; Rachel Karchin; Anne Marie Lennon; Yuchen Jiao; Laura D Wood
Journal:  Gut       Date:  2020-10-07       Impact factor: 23.059

8.  A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms.

Authors:  Chungen Lan; Xin Li; Xiuchao Wang; Jihui Hao; He Ren
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

9.  Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy.

Authors:  Stuart L Polk; Jung W Choi; Melissa J McGettigan; Trevor Rose; Abraham Ahmed; Jongphil Kim; Kun Jiang; Yoganand Balagurunathan; Jin Qi; Paola T Farah; Alisha Rathi; Jennifer B Permuth; Daniel Jeong
Journal:  World J Gastroenterol       Date:  2020-06-28       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.